Approximately 625,000 Americans will die of cancer in 2026. 125,000 will die from lung cancer. And about 20,000 Americans will die from extensive-stage small cell lung cancer (ES-SCLC), the most aggressive and deadly form of the disease. It is notorious for its resistance to traditional treatment. And despite decades of research, the only breakthrough treatment available is effective for only 35% of patients. Globally, it represents a $19B market. At Pierogi Therapeutics, we’re using physics-based machine learning methods to develop a fundamentally new kind of cancer treatment: radiotherapeutics.
News
No announcements yet — check back soon.